Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.

Mostaghel EA, Cho E, Zhang A, Alyamani M, Kaipainen A, Green S, Marck BT, Sharifi N, Wright JL, Gulati R, True LD, Loda M, Matsumoto AM, Tamae D, Penning TN, Balk SP, Kantoff PW, Nelson PS, Taplin ME, Montgomery RB.

Clin Cancer Res. 2017 Aug 15;23(16):4592-4601. doi: 10.1158/1078-0432.CCR-16-2245. Epub 2017 Apr 7.

PMID:
28389510
2.

Dose-response effects of sex hormone concentrations on body composition and adipokines in medically castrated healthy men administered graded doses of testosterone gel.

Thirumalai A, Rubinow KB, Cooper LA, Amory JK, Marck BT, Matsumoto AM, Page ST.

Clin Endocrinol (Oxf). 2017 Jul;87(1):59-67. doi: 10.1111/cen.13342. Epub 2017 Apr 26.

PMID:
28370068
3.

Neoadjuvant Enzalutamide Prior to Prostatectomy.

Montgomery B, Tretiakova MS, Joshua AM, Gleave ME, Fleshner N, Bubley GJ, Mostaghel EA, Chi KN, Lin DW, Sanda M, Novotny W, Wu K, Kantoff PW, Marck BT, Plymate S, Balk SP, Nelson PS, Matsumoto AM, Lis RT, Kibel A, Haas GP, Krivoshik A, Hannah A, Taplin ME.

Clin Cancer Res. 2017 May 1;23(9):2169-2176. doi: 10.1158/1078-0432.CCR-16-1357. Epub 2016 Nov 9.

PMID:
28151719
4.

Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.

Harrington LB, Marck BT, Wiggins KL, McKnight B, Heckbert SR, Woods NF, LaCroix AZ, Blondon M, Psaty BM, Rosendaal FR, Matsumoto AM, Smith NL.

J Thromb Haemost. 2017 Jan;15(1):80-90. doi: 10.1111/jth.13554. Epub 2017 Jan 8.

5.

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer.

McKay RR, Werner L, Mostaghel EA, Lis R, Voznesensky O, Zhang Z, Marck BT, Matsumoto AM, Domachevsky L, Zukotynski KA, Bhasin M, Bubley GJ, Montgomery B, Kantoff PW, Balk SP, Taplin ME.

Clin Cancer Res. 2017 Feb 15;23(4):935-945. doi: 10.1158/1078-0432.CCR-16-0987. Epub 2016 Sep 28. Erratum in: Clin Cancer Res. 2017 Jul 15;23 (14 ):3970.

6.

Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.

Thirumalai A, Cooper LA, Rubinow KB, Amory JK, Lin DW, Wright JL, Marck BT, Matsumoto AM, Page ST.

J Clin Endocrinol Metab. 2016 Jul;101(7):2937-44. doi: 10.1210/jc.2016-1483. Epub 2016 May 12.

7.

External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens.

Cho E, Mostaghel EA, Russell KJ, Liao JJ, Konodi MA, Kurland BF, Marck BT, Matsumoto AM, Dalkin BL, Montgomery RB.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):236-43. doi: 10.1016/j.ijrobp.2015.01.020. Epub 2015 Mar 12.

8.

Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.

Mostaghel EA, Morgan A, Zhang X, Marck BT, Xia J, Hunter-Merrill R, Gulati R, Plymate S, Vessella RL, Corey E, Higano CS, Matsumoto AM, Montgomery RB, Nelson PS.

PLoS One. 2014 Oct 30;9(10):e111545. doi: 10.1371/journal.pone.0111545. eCollection 2014.

9.

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

Taplin ME, Montgomery B, Logothetis CJ, Bubley GJ, Richie JP, Dalkin BL, Sanda MG, Davis JW, Loda M, True LD, Troncoso P, Ye H, Lis RT, Marck BT, Matsumoto AM, Balk SP, Mostaghel EA, Penning TM, Nelson PS, Xie W, Jiang Z, Haqq CM, Tamae D, Tran N, Peng W, Kheoh T, Molina A, Kantoff PW.

J Clin Oncol. 2014 Nov 20;32(33):3705-15. doi: 10.1200/JCO.2013.53.4578. Epub 2014 Oct 13.

10.

Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.

Shores MM, Arnold AM, Biggs ML, Longstreth WT Jr, Smith NL, Kizer JR, Cappola AR, Hirsch CH, Marck BT, Matsumoto AM.

Clin Endocrinol (Oxf). 2014 Nov;81(5):746-53. doi: 10.1111/cen.12452. Epub 2014 May 5.

11.

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

Roth MY, Nya-Ngatchou JJ, Lin K, Page ST, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Amory JK.

J Clin Endocrinol Metab. 2013 Mar;98(3):1198-206. doi: 10.1210/jc.2012-3527. Epub 2013 Jan 24.

12.

Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

Roth MY, Lin K, Bay K, Amory JK, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Page ST.

Fertil Steril. 2013 Jan;99(1):132-9. doi: 10.1016/j.fertnstert.2012.09.009. Epub 2012 Oct 3.

13.

Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial.

Mostaghel EA, Lin DW, Amory JK, Wright JL, Marck BT, Nelson PS, Matsumoto AM, Bremner WJ, Page ST.

J Clin Endocrinol Metab. 2012 Aug;97(8):2809-17. doi: 10.1210/jc.2012-1536. Epub 2012 Jun 1.

14.

Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants.

Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery RB.

Clin Cancer Res. 2011 Sep 15;17(18):5913-25. doi: 10.1158/1078-0432.CCR-11-0728. Epub 2011 Aug 1.

15.

Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.

Page ST, Hirano L, Gilchriest J, Dighe M, Amory JK, Marck BT, Matsumoto AM.

J Urol. 2011 Jul;186(1):191-7. doi: 10.1016/j.juro.2011.03.026. Epub 2011 May 14.

16.

Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.

Page ST, Lin DW, Mostaghel EA, Marck BT, Wright JL, Wu J, Amory JK, Nelson PS, Matsumoto AM.

J Clin Endocrinol Metab. 2011 Feb;96(2):430-7. doi: 10.1210/jc.2010-1865. Epub 2010 Dec 22.

17.
18.

Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Snyder CN, Marck BT, Bremner WJ, Amory JK.

J Clin Endocrinol Metab. 2010 Aug;95(8):3806-13. doi: 10.1210/jc.2010-0360. Epub 2010 May 19.

19.

Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery.

Yukawa M, Weigle DS, Davis CD, Marck BT, Wolden-Hanson T.

Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1453-60. doi: 10.1152/ajpregu.00035.2008. Epub 2008 Mar 12.

21.

Serum testosterone and estradiol in sudden infant death.

Emery MJ, Krous HF, Nadeau-Manning JM, Marck BT, Matsumoto AM.

J Pediatr. 2005 Nov;147(5):586-91.

PMID:
16291346
22.

Blunted hypothalamic neuropeptide gene expression in response to fasting, but preservation of feeding responses to AgRP in aging male Brown Norway rats.

Wolden-Hanson T, Marck BT, Matsumoto AM.

Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R138-46. Epub 2004 Mar 4.

23.

Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice.

Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson JA, Bennett MJ, Garcia JA.

Nat Genet. 2003 Dec;35(4):331-40. Epub 2003 Nov 9.

PMID:
14608355
24.

Neonatal 6-hydroxydopamine administration to mice is fatal.

Brot MD, Szczypka MS, Reavell R, Marck BT, Matsumoto AM, Palmiter RD.

Dev Neurosci. 2002;24(6):531-8.

PMID:
12697991
25.

Suppression of hypothalamic pro-opiomelanocortin (POMC) gene expression by daily melatonin supplementation in aging rats.

Rasmussen DD, Marck BT, Boldt BM, Yellon SM, Matsumoto AM.

J Pineal Res. 2003 Mar;34(2):127-33.

PMID:
12562504
26.
27.

Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation.

Chartoff EH, Marck BT, Matsumoto AM, Dorsa DM, Palmiter RD.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10451-6. Epub 2001 Aug 21.

28.

Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice.

Szczypka MS, Kwok K, Brot MD, Marck BT, Matsumoto AM, Donahue BA, Palmiter RD.

Neuron. 2001 Jun;30(3):819-28.

29.

Aging and the neuroendocrine regulation of reproduction and body weight.

Matsumoto AM, Marck BT, Gruenewald DA, Wolden-Hanson T, Naai MA.

Exp Gerontol. 2000 Dec;35(9-10):1251-65.

PMID:
11113606
31.

Feeding behavior in dopamine-deficient mice.

Szczypka MS, Rainey MA, Kim DS, Alaynick WA, Marck BT, Matsumoto AM, Palmiter RD.

Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12138-43.

32.
33.

Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase.

Thomas SA, Marck BT, Palmiter RD, Matsumoto AM.

J Neurochem. 1998 Jun;70(6):2468-76.

34.
35.

Supplemental Content

Loading ...
Support Center